Search - tctmd.com

Displaying 661 - 680 of 854

Sort: Relevancy | Date

News Conference News ESC 2014

GARY: Transapical TAVR Appears Inherently Riskier Than Transvascular

Caitlin E. Cox

September 02, 2014

News Daily News

第一代TAVR器械之间的主动脉反流风险和结果不同

Caitlin E. Cox

August 07, 2014

News Daily News

Las Consecuencias del Riesgo de Regurgitación Aórtica Varían entre los Dispositivos TAVR de 1ª Generación

Caitlin E. Cox

August 07, 2014

News Daily News

Aortic Regurgitation Risk, Consequences Vary Between First-Generation TAVR Devices

Caitlin E. Cox

August 07, 2014

News Daily News

利用CMR技术新发现的TAVR后心肌损伤与左室功能降低有关系

Yael L. Maxwell

July 24, 2014

News Daily News

Una Nueva Lesión Miocárdica Post-TAVR Identificada mediante RMC se asocia a una Menor LVEF

Yael L. Maxwell

July 24, 2014

News Daily News

New CMR-Identified Myocardial Injury Post-TAVR Linked With Decreased LV Function

Yael L. Maxwell

July 24, 2014

News Industry News

Results of first-in-human study of Transcatheter Technologies’ TAVI device, TRINITY, are reported in(1)

July 22, 2014

News Industry News

Results of first-in-human study of Transcatheter Technologies’ TAVI device, TRINITY, are reported in EuroIntervention

July 22, 2014

News Industry News

Boston Scientific Receives CE Mark For The New 25 mm Lotus™ Valve System

July 14, 2014

News Industry News

JENAVALVE ANNOUNCES FIRST IMPLANTATION OF TRANSAPICAL TAVI SYSTEM IN SWEDEN

June 04, 2014

News Industry News

Boston Scientific Initiates the RESPOND Post Market Registry Evaluating Clinical Outcomes in Patients Implanted With Lotus™ Valve System

June 04, 2014

News Industry News

Transcatheter Technologies receives Second tranche of Series B cash infusion

June 02, 2014

News Conference News EuroPCR 2014

EuroPCR 2014: Clinical Challenges, Novel Innovations Share the Limelight

Caitlin E. Cox

May 28, 2014

News Conference News EuroPCR 2014

UK Registry Finds Long-Term Survival After TAVR Depends on Patient Characteristics

Caitlin E. Cox

May 22, 2014

News Industry News

DIRECT FLOW MEDICAL® TRANSCATHETER AORTIC VALVE SYSTEM DEMONSTRATES EXCELLENT 12 MONTH OUTCOMES IN DISCOVER CE MARK TRIAL

May 22, 2014

News Industry News

PRIMARY ENDPOINT DATA PRESENTED ON PERFORMANCE AND SAFETY OF THE JENAVALVE TAVI SYSTEM

May 21, 2014

News Industry News

Medtronic CoreValve® System Demonstrates Positive Clinical Performance at Two Years in 'Real World' ADVANCE Study

May 21, 2014

News Industry News

Boston Scientific Lotus™ Valve System Demonstrates Strong Performance And Safety Profile At Six Months

May 21, 2014

News Industry News

Medtronic Announces CE Mark and Launch of NC Euphora(TM) Coronary Balloon

May 20, 2014

Advertisement

GARY: Transapical TAVR Appears Inherently Riskier Than Transvascular

第一代TAVR器械之间的主动脉反流风险和结果不同

Las Consecuencias del Riesgo de Regurgitación Aórtica Varían entre los Dispositivos TAVR de 1ª Generación

Aortic Regurgitation Risk, Consequences Vary Between First-Generation TAVR Devices

利用CMR技术新发现的TAVR后心肌损伤与左室功能降低有关系

Una Nueva Lesión Miocárdica Post-TAVR Identificada mediante RMC se asocia a una Menor LVEF

New CMR-Identified Myocardial Injury Post-TAVR Linked With Decreased LV Function

Results of first-in-human study of Transcatheter Technologies’ TAVI device, TRINITY, are reported in(1)

Results of first-in-human study of Transcatheter Technologies’ TAVI device, TRINITY, are reported in EuroIntervention

Boston Scientific Receives CE Mark For The New 25 mm Lotus™ Valve System

JENAVALVE ANNOUNCES FIRST IMPLANTATION OF TRANSAPICAL TAVI SYSTEM IN SWEDEN

Boston Scientific Initiates the RESPOND Post Market Registry Evaluating Clinical Outcomes in Patients Implanted With Lotus™ Valve System

Transcatheter Technologies receives Second tranche of Series B cash infusion

EuroPCR 2014: Clinical Challenges, Novel Innovations Share the Limelight

UK Registry Finds Long-Term Survival After TAVR Depends on Patient Characteristics

DIRECT FLOW MEDICAL® TRANSCATHETER AORTIC VALVE SYSTEM DEMONSTRATES EXCELLENT 12 MONTH OUTCOMES IN DISCOVER CE MARK TRIAL

PRIMARY ENDPOINT DATA PRESENTED ON PERFORMANCE AND SAFETY OF THE JENAVALVE TAVI SYSTEM

Medtronic CoreValve® System Demonstrates Positive Clinical Performance at Two Years in 'Real World' ADVANCE Study

Boston Scientific Lotus™ Valve System Demonstrates Strong Performance And Safety Profile At Six Months

Medtronic Announces CE Mark and Launch of NC Euphora(TM) Coronary Balloon

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content